Biomea Fusion (BMEA) Price & Analysis

Compare

855 Followers

BMEA Stock Chart & Stats

Day’s Range― - ―

52-Week Range$1.29 - $13.07

Previous CloseN/A

Volume309.16K

Average Volume (3M)705.35K

Market Cap

$116.04M

Enterprise Value$23.96M

Total Cash (Recent Filing)$56.22M

Total Debt (Recent Filing)$7.05M

Price to Earnings (P/E)―

Beta1.31

Next Earnings

Nov 04, 2025

EPS Estimate

-0.31

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.51

Shares Outstanding59,508,520

10 Day Avg. Volume570,255

30 Day Avg. Volume705,354

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap0.21

Enterprise Value/Revenue19.64

Enterprise Value/Gross Profit74.89

Enterprise Value/Ebitda-0.21

Forecast

1Y Price Target

$7.00

Price Target Upside258.97% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Clinical TrialsFDA feedback on plans for a likely pivotal trial in severe insulin deficient diabetes presents a good setup.

Combination TherapyIcovamenib as a potential combo therapy with GLP-1s could improve tolerability and preserve lean mass without losing efficacy.

Stock RatingAnalyst maintains a Buy rating with a high-risk short-term view, indicating confidence in potential upside.

Bears Say

Financial PerformanceBiomea announced 2Q25 financial results, posting EPS of ($0.51) compared to our estimate of ($0.46), and in line with consensus.

Operational EfficiencyResearch and development and SG&A spending are reduced to exclude oncology-related expenses, reflecting a 35% staff cut.

Strategic RealignmentThe price target for Biomea Fusion is lowered to $9 due to a strategic realignment focusing solely on metabolic disease and no longer pursuing oncology.

Biomea Fusion News

Five Below upgraded, Bill downgraded: Wall Street’s top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here...

4d ago

AHL

Biomea Fusion initiated with a Buy at Jefferies

Jefferies initiated coverage of Biomea Fusion (BMEA) with a Buy rating and $5 price target Biomea is a...

4d ago

BMEA

Biomea Fusion price target lowered to $7 from $9 at Citi

Citi analyst Yigal Nochomovitz lowered the firm’s price target on Biomea Fusion (BMEA) to $7 from $9 and...

21d ago

BMEA

Biomea Fusion price target lowered to $10 from $30 at Scotiabank

Scotiabank lowered the firm’s price target on Biomea Fusion (BMEA) to $10 from $30 and keeps an Outperform...

26d ago

BMEA

Biomea Fusion price target lowered to $9 from $10 at Oppenheimer

Oppenheimer analyst Matthew Biegler lowered the firm’s price target on Biomea Fusion (BMEA) to $9 from $10 and...

27d ago

BMEA

Biomea Fusion files $300M mixed securities shelf

16:42 EDT Biomea Fusion (BMEA) files $300M mixed securities shelf Published first on TheFly – the ultimate source...

27d ago

BMEA

Biomea Fusion reports Q2 EPS (51c), consensus (51c)

“In the second quarter, we presented clinical and preclinical results with icovamenib that support its unique role as...

27d ago

BMEA

Biomea Fusion: Promising Trials and Strategic Innovations Drive Buy Rating

Yigal Nochomovitz, an analyst from Citi, maintained the Buy rating on Biomea Fusion. The associated price target was...

21d ago

BMEA

Promising Developments in Biomea Fusion’s Metabolic Programs Justify Buy Rating

Biomea Fusion, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Joseph Pantginis from...

26d ago

BMEA

Biomea Fusion Reports Q2 2025 Financial Results

Biomea Fusion Inc ( ($BMEA) ) has released its Q2 earnings. Here is a breakdown of the information...

26d ago

BMEA

Biomea Fusion Announces Leadership Changes in Board

The latest announcement is out from Biomea Fusion ( ($BMEA) ). On July 22, 2025, Bihua Chen resigned...

1M ago

BMEA

Biomea Fusion appoints Julianne Averill to board of directors

Biomea Fusion (BMEA) announced the appointment of Julianne Averill to its Board of Directors, effective July 22, 2025....

1M ago

BMEA

Biomea Fusion price target lowered to $9 from $22 at Citi

Citi lowered the firm’s price target on Biomea Fusion (BMEA) to $9 from $22 and keeps a Buy...

2M ago

BMEA

Biomea Fusion’s Phase 2 Trial: A New Hope for Type 1 Diabetes Treatment

Biomea Fusion Inc (($BMEA)) announced an update on their ongoing clinical study. Biomea Fusion Inc. is conducting a...

2M ago

BMEA

BMEA FAQ

What was Biomea Fusion’s price range in the past 12 months?

Biomea Fusion lowest stock price was $1.29 and its highest was $13.07 in the past 12 months.

What is Biomea Fusion’s market cap?

Biomea Fusion’s market cap is $116.04M.

When is Biomea Fusion’s upcoming earnings report date?

Biomea Fusion’s upcoming earnings report date is Nov 04, 2025 which is in 64 days.

How were Biomea Fusion’s earnings last quarter?

Biomea Fusion released its earnings results on Aug 05, 2025. The company reported -$0.51 earnings per share for the quarter, beating the consensus estimate of -$0.531 by $0.021.

Is Biomea Fusion overvalued?

According to Wall Street analysts Biomea Fusion’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Biomea Fusion pay dividends?

Biomea Fusion does not currently pay dividends.

What is Biomea Fusion’s EPS estimate?

Biomea Fusion’s EPS estimate is -0.31.

How many shares outstanding does Biomea Fusion have?

Biomea Fusion has 59,508,520 shares outstanding.

What happened to Biomea Fusion’s price movement after its last earnings report?

Biomea Fusion reported an EPS of -$0.51 in its last earnings report, beating expectations of -$0.531. Following the earnings report the stock price went up 0.633%.

Which hedge fund is a major shareholder of Biomea Fusion?

Currently, no hedge funds are holding shares in BMEA

Biomea Fusion Stock Smart Score

Neutral

Fundamentals

Return on Equity

-170.53%

Trailing 12-Months

Asset Growth

-46.27%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Biomea Fusion

Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in oncogenic signaling in multiple cancers. The company was incorporated in 2017 and is headquartered in Redwood City, California.

Biomea Fusion (BMEA) Earnings & Revenues

Historic Earnings Reports

BMEA Stock 12 Month Forecast

Average Price Target

$7.00

▲(258.97% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"$0","11":"$11","2.75":"$2.75","5.5":"$5.5","8.25":"$8.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":10,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$10.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$7.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[0,2.75,5.5,8.25,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,2.2184615384615385,2.8669230769230767,3.5153846153846153,4.163846153846154,4.812307692307693,5.46076923076923,6.109230769230769,6.757692307692308,7.406153846153846,8.054615384615385,8.703076923076923,9.35153846153846,{"y":10,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.9876923076923076,2.4053846153846155,2.823076923076923,3.2407692307692306,3.6584615384615384,4.076153846153846,4.493846153846154,4.911538461538462,5.32923076923077,5.7469230769230775,6.164615384615385,6.582307692307692,{"y":7,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,1.57,1.756923076923077,1.9438461538461538,2.1307692307692307,2.3176923076923077,2.5046153846153847,2.691538461538461,2.878461538461538,3.065384615384615,3.252307692307692,3.439230769230769,3.626153846153846,3.813076923076923,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.42,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.75,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.33,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.5,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.04,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.27,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.88,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.89,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.99,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.03,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.55,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.72,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.57,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >